Thinking of joining a study?

Register your interest

NCT05635266 | RECRUITING | Age-Related Macular Degeneration


Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Sponsor:

Sanguine Biosciences

Brief Summary:

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and develop new treatments, diagnostics, and preventative methods for specific and complex conditions.

Condition or disease

Age-Related Macular Degeneration

Allergies

Alpha-Gal Syndrome

Alzheimer Disease

Amyloidosis

Ankylosing Spondylitis

Arthritis

Alopecia Areata

Asthma

Atopic Dermatitis

Autism

Autoimmune Hepatitis

Behcet's Disease

Beta-Thalassemia

Cancer

Celiac Disease

Kidney Diseases

COPD

Crohn Disease

Cystic Fibrosis

Diabetes

Driven Syndrome

DMD

Fibromyalgia

Graves Disease

Thyroid Diseases

Hepatitis

Hidradenitis suppurativa

ITP

Leukemia

IF

Lupus or SLE

Lymphoma

Multiple Sclerosis

Myasthenia Gravis

Heart Diseases

Parkinson Disease

Pemphigus Vulgaris

Cirrhosis

Psoriasis

Schizophrenia

Scleroderma

Sickle Cell Disease

Stroke

Ulcerative Colitis

Vasculitis

Vitiligo

Intervention/treatment

Specimen sample

Study Type : OBSERVATIONAL
Estimated Enrollment : 20000 participants
Official Title : A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Actual Study Start Date : 2021-10-26
Estimated Primary Completion Date : 2025-10
Estimated Study Completion Date : 2025-10

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 85 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria
  • * Persons 18 to 85 years of age at the date of informed consent.
  • * If presenting with a history of a specific condition, the diagnosis is confirmable in the medical record or may be confirmed using other forms of verification including self-reporting.
  • * Understands the procedures and requirements of the study by providing written informed consent (or verbal assent if a legally authorized representative will sign the ICF), including consent for authorization for protected health information disclosure.
Exclusion Criteria
  • * Persons younger than 18 years of age or older than 85 years of age at the date of informed consent.
  • * Receipt of blood products 30 days before the study blood draw.
  • * Receipt of an investigational (unapproved) drug 30 days before the study blood draw.
  • * A confirmable diagnosis of any medical condition that would increase potential phlebotomy risks.
  • * Has donated a unit of blood within the last 2 months at the date of informed consent.

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Location Details

NCT05635266


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, Massachusetts

Sanguine Biosciences

Waltham, Massachusetts, United States, 02451

Loading...